NIGMS National and Regional Resources (R24)

The NIGMS National and Regional Resources (R24) program supports resources that provide access to state-of-the-art facilities, equipment, technologies, research tools, software, and service to a substantial number of users on a national or multiple state regional basis. These are established resources previously developed with NIGMS support or formed through consolidation of multiple local or regional facilities that have previously received NIGMS support. They are expected to yield significant economies of scale and significantly increase access to the supported technologies or services for researchers at multiple institutions. Major new research and development efforts are not supported by this mechanism. Only those resources whose technical capabilities will serve investigators in the program areas of NIGMS are supported. Researchers with similar needs supported by other sources of funding are also able to access these resources through competitive application processes. Stand-alone data resources and databases are not supported by this mechanism. The resources will be maintained and upgraded to maintain the state-of-the art, will make their capabilities and availability known to the biomedical research community through outreach activities, and provide user training and support.

The NIGMS Strategic Plan [PDF, 702KB] indicates its commitment to support the development of and access to essential research tools, resources, and capabilities for biomedical research. Several grant mechanisms are used to meet the objectives under this broad statement. R21 and R01 technology development Funding Opportunity Announcements are designed to support the creation of new technology and methods. The P41 Biomedical Technology Research Resources (BTRR) program is used to develop centers with a critical mass of unique technological and intellectual capacity at the forefront of their fields. The Institutional Development Award (IDeA) program supports the development of institutional biomedical research infrastructure through Centers of Biomedical Research Excellence (COBRE) and IDeA Networks of Biomedical Research Excellence (INBRE) core facilities.

The Limited Competition: NIGMS National and Regional Resources (R24 – Clinical Trial Not Allowed) Funding Opportunity Announcement (PAR-19-301) provides a means to apply for support of resources developed through the above mentioned and other previous NIGMS grant awards.